Leaders
Apogee's former leaders join Paragon Labs after $10.9 billion sale
Michael Henderson and four other executives will steer drug candidates discovered by Paragon into clinical testing and new startups.
Alaunos Therapeutics
Leaders
Michael Henderson and four other executives will steer drug candidates discovered by Paragon into clinical testing and new startups.